Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

SCIEX Biopharma & Pharma SolutionsSCIEX Biopharma & Pharma Solutions
VS
GenentechGenentech
SCIEX Biopharma & Pharma Solutions

SCIEX Biopharma & Pharma Solutions

500 Old Connecticut Path, Framingham, 01701, US

Last Update: 28/12/2025

View Profile
Between 750 and 799
https://sciex.li/1jg90e
754/1000Fair

To bring safe and effective therapies to market, it is vital for pharma and biopharma research to have the right information available at every stage of the process. Transform your analytical workflows by collaborating with a team that is devoted to advancing pharma an...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:None
Subsidiaries:67
12-month incidents
0
Known data breaches
0
Attack type number
0
Genentech

Genentech

1 Dna Way, South San Francisco, California, US, 94080

Last Update: 01/04/2026

View Profile
Between 750 and 799
http://www.gene.com
794/1000Fair

About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a differe...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:18,082
Subsidiaries:50
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
SCIEX Biopharma & Pharma Solutions

SCIEX Biopharma & Pharma Solutions

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Genentech

Genentech

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for SCIEX Biopharma & Pharma Solutions in 2026.

Incidents

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Genentech in 2026.

Incidents

Incident History - SCIEX Biopharma & Pharma Solutions (X = Date, Y = Severity)

SCIEX Biopharma & Pharma Solutions cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Genentech (X = Date, Y = Severity)

Genentech cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
SCIEX Biopharma & Pharma Solutions

SCIEX Biopharma & Pharma Solutions

Incidents
No explicit notable incidents reported.
Genentech

Genentech

Incidents
No explicit notable incidents reported.

FAQ

Between SCIEX Biopharma & Pharma Solutions company and Genentech company, which one has the best AI Cybersecurity Score ?
Between SCIEX Biopharma & Pharma Solutions company and Genentech company, which one has experienced more cyber incidents in the past ?
Between SCIEX Biopharma & Pharma Solutions company and Genentech company, which one has experienced more cyber incidents this year ?
Between SCIEX Biopharma & Pharma Solutions company and Genentech company, which one has experienced at least one ransomware attack ?
Between SCIEX Biopharma & Pharma Solutions company and Genentech company, which one has experienced at least one data breach ?
Between SCIEX Biopharma & Pharma Solutions company and Genentech company, which one has experienced at least one targeted cyberattack ?
Between SCIEX Biopharma & Pharma Solutions company and Genentech company, which one has experienced at least one vulnerability ?
Between SCIEX Biopharma & Pharma Solutions company and Genentech company, which one holds the most compliance certifications ?
Between SCIEX Biopharma & Pharma Solutions company and Genentech company, which one holds the fewest compliance certifications ?
Between SCIEX Biopharma & Pharma Solutions company and Genentech company, which one has the most subsidiaries ?
Between SCIEX Biopharma & Pharma Solutions company and Genentech company, which one has the largest number of employees ?
Between SCIEX Biopharma & Pharma Solutions and Genentech, which company holds both SOC 2 Type 1 certifications ?
Between SCIEX Biopharma & Pharma Solutions and Genentech, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - SCIEX Biopharma & Pharma Solutions or Genentech ?
Which company is PCI DSS compliant - SCIEX Biopharma & Pharma Solutions or Genentech ?
Between SCIEX Biopharma & Pharma Solutions and Genentech, which company complies with HIPAA regulations for healthcare data ?
Between SCIEX Biopharma & Pharma Solutions and Genentech, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-8325
SUMMARY

A maliciously crafted PDF file, when parsed through Autodesk Revit, can force an Out-of-Bounds Write vulnerability. A malicious actor may leverage this vulnerability to cause a crash, cause data corruption, or execute arbitrary code in the context of the current process.

PUBLISHED
Date2026-08-06
UPDATED
Date2026-08-06
RISK INFORMATION (Score: 7.8)
CVSS3
Base Score: 7.8
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
1.8
CVE-2026-7867
SUMMARY

A flaw was found in udisks2. A local attacker with an active console session can exploit insufficient authorization checking on the 'as-user' option in the org.freedesktop.UDisks2.Filesystem.Mount() D-Bus method. This allows the attacker to spoof the 'as-user' parameter, mounting filesystems on behalf of arbitrary users, including privileged accounts. This can lead to local privilege escalation through mount point injection and manipulation of the mount namespace visible to privileged users.

PUBLISHED
Date2026-08-06
UPDATED
Date2026-08-06
RISK INFORMATION (Score: 7.8)
CVSS3
Base Score: 7.8
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
1.8
CVE-2026-7406
SUMMARY

A maliciously crafted BMP file, when parsed through certain Autodesk products, can force a Untrusted Pointer Dereference vulnerability. A malicious actor can leverage this vulnerability to execute arbitrary code in the context of the current process.

PUBLISHED
Date2026-08-06
UPDATED
Date2026-08-06
RISK INFORMATION (Score: 7.8)
CVSS3
Base Score: 7.8
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
1.8
CVE-2026-7405
SUMMARY

A maliciously crafted TIF file, when parsed through certain Autodesk products during image import, can cause an Out-of-Bounds Read in the image handling library. A malicious actor can leverage this vulnerability to cause a denial of service

PUBLISHED
Date2026-08-06
UPDATED
Date2026-08-06
RISK INFORMATION (Score: 5.5)
CVSS3
Base Score: 5.5
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
1.8
CVE-2026-71555
SUMMARY

PILOS (Platform for Interactive Live-Online Seminars) is a frontend for BigBlueButton. From 2.1.0 until 4.14.1, PILOS does not send a Cross-Origin-Opener-Policy response header, so pages opened by PILOS via a link that opens a new browsing context (e.g., target="_blank") retain a window.opener reference back to the originating PILOS tab. A malicious destination page reached this way can use window.opener to navigate or manipulate the original PILOS tab, a technique known as reverse tabnabbing, potentially redirecting an authenticated user to a phishing page that mimics PILOS. This issue is fixed in version 4.14.1.

PUBLISHED
Date2026-08-06
UPDATED
Date2026-08-06
RISK INFORMATION (Score: 4.1)
CVSS3
Base Score: 4.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:N/I:L/A:N
IMPACT SCORE
1.4
EXPLOITABILITY
2.3